Cowen Inc’s bluebird bio BLUE Stock Holding History

Cowen Inc’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.91M	Buy	1,158 +540	+87%	+$934K	0.14%	118
2019 Q1	$1.26M	Buy	+618	New	+$1.09M	0.14%	98
2018 Q3	–	Sell	-463	Closed	-$942	–	518
2018 Q2	$942	Buy	+463	New	+$1.06M	0.04%	218
2015 Q3	–	Sell	-245	Closed	-$533K	–	277
2015 Q2	$533K	Sell	245 -127	-34%	-$259K	0.03%	231
2015 Q1	$582K	Sell	372 -7,134	-95%	-$9.41M	0.05%	207
2014 Q4	$8.92M	Buy	7,506 +372	+5%	+$249K	0.7%	23
2014 Q3	$3.32M	Hold	7,134	–	–	0.34%	81
2014 Q2	$3.56M	Sell	7,134 -912	-11%	-$292K	0.4%	78
2014 Q1	$2.37M	Sell	8,046 -4,206	-34%	-$1.27M	0.29%	77
2013 Q4	$3.33M	Buy	+12,252	New	+$3.42M	0.56%	32

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cowen Inc's BLUE Position: Q2 2019 in Review

Cowen Inc increased its bluebird bio (BLUE) stake by 87% in Q2 2019, buying an estimated $934K and bringing the position to 1,158 shares worth $1.91M. The position accounts for 0.14% of the portfolio, ranked #118.

Cowen Inc first reported a position in BLUE in Q4 2013 and has held it in 10 quarters since. The position peaked at $8.92M in Q4 2014. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

Cowen Inc held 1,158 shares of bluebird bio worth $1.91M as of Q2 2019.
Cowen Inc bought 540 bluebird bio shares in Q2 2019, an estimated $934K.
bluebird bio made up 0.14% of Cowen Inc's portfolio in Q2 2019, its #118 holding.
Cowen Inc first reported a position in bluebird bio in Q4 2013 and has held it in 10 quarters since.
Cowen Inc's bluebird bio position peaked at $8.92M in Q4 2014.
273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.